Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose remifentanil and reversal of capsaicin-induced hyperalgesia in healthy volunteers
2009-011599-31Phase 4Completed
- Sponsor
- Medical University of Vienna, University Clinic for Anesthesiology, General
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of remifentanil in hyperalgesia, sponsored by Medical University of Vienna, University Clinic for Anesthesiology, General. Primary endpoint: Area of pinprick hyperalgesia at 6 hours after discontinuation of remifentanil. Started Apr 2009; status: completed.
02
Drugs
remifentanil
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on 2009-011599-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011599-31.